Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Non-Metabolic Role of PKM2 in Regulation of the HIV-1 LTR.

Sen S, Deshmane SL, Kaminski R, Amini S, Datta PK.

J Cell Physiol. 2017 Mar;232(3):517-525. doi: 10.1002/jcp.25445. Epub 2016 Jun 10.

2.

Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins.

Deshmane SL, Amini S, Sen S, Khalili K, Sawaya BE.

Virol J. 2011 Oct 24;8:477. doi: 10.1186/1743-422X-8-477.

3.

High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons.

Deshmane SL, Mukerjee R, Fan S, Sawaya BE.

PLoS One. 2011 Jan 7;6(1):e16148. doi: 10.1371/journal.pone.0016148.

4.

IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth.

Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, Pascale M, d'Avenia M, Marzullo L, Belisario MA, De Marco M, Barbieri A, Giudice A, Chiappetta G, Vuttariello E, Monaco M, Bonelli P, Salvatore G, Di Benedetto M, Deshmane SL, Khalili K, Turco MC, Leone A.

Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7497-502. doi: 10.1073/pnas.0907696107. Epub 2010 Apr 5.

5.

Modulation of JC virus transcription by C/EBPbeta.

Romagnoli L, Wollebo HS, Deshmane SL, Mukerjee R, Del Valle L, Safak M, Khalili K, White MK.

Virus Res. 2009 Dec;146(1-2):97-106. doi: 10.1016/j.virusres.2009.09.005. Epub 2009 Sep 9.

6.

Monocyte chemoattractant protein-1 (MCP-1): an overview.

Deshmane SL, Kremlev S, Amini S, Sawaya BE.

J Interferon Cytokine Res. 2009 Jun;29(6):313-26. doi: 10.1089/jir.2008.0027. Review.

7.

HIV-1 Vpr deregulates calcium secretion in neural cells.

Rom I, Deshmane SL, Mukerjee R, Khalili K, Amini S, Sawaya BE.

Brain Res. 2009 Jun 12;1275:81-6. doi: 10.1016/j.brainres.2009.03.024. Epub 2009 Mar 25.

8.

Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression.

Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, Sweet T, Rom I, Khalili K, Rappaport J, Amini S, Sawaya BE.

J Biol Chem. 2009 Apr 24;284(17):11364-73. doi: 10.1074/jbc.M809266200. Epub 2009 Feb 9.

9.

TNF alpha production in morphine-treated human neural cells is NF-kappaB-dependent.

Sawaya BE, Deshmane SL, Mukerjee R, Fan S, Khalili K.

J Neuroimmune Pharmacol. 2009 Mar;4(1):140-9. doi: 10.1007/s11481-008-9137-z. Epub 2008 Nov 21.

PMID:
19023660
10.

Protective role of Puralpha to cisplatin.

Kaminski R, Darbinyan A, Merabova N, Deshmane SL, White MK, Khalili K.

Cancer Biol Ther. 2008 Dec;7(12):1926-35. Epub 2008 Dec 8.

11.

BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells.

Rosati A, Khalili K, Deshmane SL, Radhakrishnan S, Pascale M, Turco MC, Marzullo L.

J Cell Physiol. 2009 Feb;218(2):264-7. doi: 10.1002/jcp.21604.

12.

Involvement of the p53 and p73 transcription factors in neuroAIDS.

Mukerjee R, Deshmane SL, Fan S, Del Valle L, White MK, Khalili K, Amini S, Sawaya BE.

Cell Cycle. 2008 Sep 1;7(17):2682-90. Epub 2008 Sep 17.

13.

St. John's Wort protein, p27SJ, regulates the MCP-1 promoter.

Mukerjee R, Deshmane SL, Darbinian N, Czernik M, Khalili K, Amini S, Sawaya BE.

Mol Immunol. 2008 Sep;45(15):4028-35. doi: 10.1016/j.molimm.2008.06.001. Epub 2008 Jul 22.

14.

JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis.

Merabova N, Kaniowska D, Kaminski R, Deshmane SL, White MK, Amini S, Darbinyan A, Khalili K.

J Virol. 2008 Feb;82(3):1558-69. Epub 2007 Nov 7.

15.

Molecular mimicry in inducing DNA damage between HIV-1 Vpr and the anticancer agent, cisplatin.

Siddiqui K, Del Valle L, Morellet N, Cui J, Ghafouri M, Mukerjee R, Urbanska K, Fan S, Pattillo CB, Deshmane SL, Kiani MF, Ansari R, Khalili K, Roques BP, Reiss K, Bouaziz S, Amini S, Srinivasan A, Sawaya BE.

Oncogene. 2008 Jan 3;27(1):32-43. Epub 2007 Jul 23.

PMID:
17653096
16.

C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.

Mameli G, Deshmane SL, Ghafouri M, Cui J, Simbiri K, Khalili K, Mukerjee R, Dolei A, Amini S, Sawaya BE.

J Gen Virol. 2007 Feb;88(Pt 2):631-40.

PMID:
17251582
17.

Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region.

White MK, Skowronska A, Gordon J, Del Valle L, Deshmane SL, Giordano A, Khalili K.

Anticancer Res. 2006 Nov-Dec;26(6B):4079-92.

18.

MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.

Eldeen MB, Deshmane SL, Simbiri K, Khalili K, Amini S, Sawaya BE.

J Neuroimmunol. 2006 Jul;176(1-2):174-80. Epub 2006 Jun 5.

PMID:
16750572
19.

Increased susceptibility to the pathogenic effects of wild-type and recombinant herpesviruses in MPS VII mice compared to normal siblings.

Wolfe JH, Martin CE, Deshmane SL, Reilly JJ, Kesari S, Fraser NW.

J Neurovirol. 1996 Dec;2(6):417-22.

PMID:
8972424
20.

The replicating intermediates of herpes simplex virus type 1 DNA are relatively short.

Deshmane SL, Raengsakulrach B, Berson JF, Fraser NW.

J Neurovirol. 1995 Jun;1(2):165-76.

PMID:
9222355
21.
23.

A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.

Valyi-Nagy T, Gesser RM, Raengsakulrach B, Deshmane SL, Randazzo BP, Dillner AJ, Fraser NW.

Virology. 1994 Mar;199(2):484-90.

PMID:
8122378
24.
25.

An HSV-1 mutant lacking the LAT TATA element reactivates normally in explant cocultivation.

Deshmane SL, Nicosia M, Valyi-Nagy T, Feldman LT, Dillner A, Fraser NW.

Virology. 1993 Oct;196(2):868-72.

PMID:
8396815
26.

Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Gesser RM, Wysocka M, Dillner A, Fraser NW.

J Virol. 1992 Dec;66(12):7336-45.

27.
28.

In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.

Trousdale MD, Steiner I, Spivack JG, Deshmane SL, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW.

J Virol. 1991 Dec;65(12):6989-93.

29.
30.

A review of the molecular mechanism of HSV-1 latency.

Fraser NW, Spivack JG, Wroblewska Z, Block T, Deshmane SL, Valyi-Nagy T, Natarajan R, Gesser RM.

Curr Eye Res. 1991;10 Suppl:1-13. Review.

PMID:
1650659
31.

Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia.

Mitchell WJ, Deshmane SL, Dolan A, McGeoch DJ, Fraser NW.

J Virol. 1990 Nov;64(11):5342-8.

34.

Cross-reactivity of antigens specified by Japanese encephalitis & West Nile viruses.

Banerjee K, Deshmane SL.

Indian J Med Res. 1987 Apr;85:339-46. No abstract available.

PMID:
3623642
35.

Polypeptides of Japanese encephalitis and West Nile viruses.

Deshmane SL, Banerjee K.

Indian J Med Res. 1980 Feb;71:157-63. No abstract available.

PMID:
7380489

Supplemental Content

Loading ...
Support Center